Remove | Remove | |
![]() |
![]() |
|
Title | Laidlomycin Propionate Potassium | Desamino Hydroxy Descyclopropyl Lenvatinib |
Add to cart |
|
|
Description |
Laidlomycin Propionate Potassiumis chemically Potassium (2S,3R,4R)-4-((2R,5R,7S,8R,9S)-9-hydroxy-2-((2R,2’R,3’S,5R,5’S)-5′-((2S,3S,5R,6R)-6-hydroxy-3,5-dimethyl-6-((propionyloxy)methyl)tetrahydro-2H-pyran-2-yl)-2,3′-dimethyloctahydro-[2,2′-bifuran]-5-yl)-2,8-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl)-2-methyl-3-(propionyloxy)pentanoate. Laidlomycin Propionate Potassium is supplied with detailed characterization data compliant with regulatory guideline. Laidlomycin Propionate Potassium can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Laidlomycin.The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use. |
Desamino Hydroxy Descyclopropyl Lenvatinib is chemically 4-(3-Chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxylic acid. The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. ISP Standards products are for analytical purpose only and not for human use. |
Availability | In stock | In stock |
CAS No | 84799-02-0 | 2733083-03-7 |
Inv. Status | Custom Synthesis | In Stock |
Mol.F. | C40H65O13 : K | C18H14ClN3O5 |
ISP CAT No | ISP-L080001 | ISP-L038004 |
Mol.Wt. | 753.9 : 39.1 | 387.8 |